GelTex, Genzyme Corp. General Division deal

The companies formed RenaGel LLC, a joint venture to finalize development and commercialize GELX's RenaGel non-absorbed phosphate binder to control

Read the full 207 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE